Harry Miskin

Equibles does not estimate personal net worth.

Get an email with a short summary when Tg Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TGTX alerts

About Harry Miskin

Harry Miskin has spoken on 1 earnings call across 1 company, most recently for Tg Therapeutics, Inc. on November 9, 2026. Tg Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tg Therapeutics, Inc. includes Michael S. Weiss (CEO and Board Member), Sean A. Power (CFO), Daniel Hume (Board Member) and 7 others.

Harry Miskin on recent calls

“I'm pleased to join you all today to provide an update on our clinic development programs and highlights of our recently presented data.”

Other, TG Therapeutics Q3 2026 Financial Results and Business Update · November 9, 2026

Affiliation history

Tg Therapeutics, Inc. (TGTX)
Transcript header (unverified)

Current

Company network

Tg Therapeutics, Inc.

TGTX

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-11-09

View calls and events

Leadership on record at Tg Therapeutics, Inc.

Michael S. Weiss CEO, Board Member
Sean A. Power CFO
Daniel Hume Board Member
Dr. Sagar Lonial Board Member
Kenneth Hoberman Board Member
Laurence Charney Board Member
Laurence N. Charney Board Member
Sagar Lonial Board Member
Sagar Lonial, MD Board Member
Yann Echelard Board Member

Recent activity

Earnings call TG Therapeutics Q3 2026 Financial Results and Business Update Tg Therapeutics, Inc. (TGTX)
2026-11-09